The Chengdu-Chongqing economic circle is accelerating the construction of a biopharmaceutical industry cluster with national influence. It has formed a full industrial chain system covering R&D, production and application, and has become a key pole in the national biopharmaceutical map. However, the biopharmaceutical industry in Chengdu-Chongqing faces some problems, which restrict the release of industrial potential and affect regional coordinated development. By optimizing the review and approval mechanism of Chengdu-Chongqing biopharmaceuticals, the bottleneck of industrial development can be effectively solved. Measures such as building the Chengdu-Chongqing branch of the National Drug and Medical Device Review Center, supporting Chengdu-Chongqing institutions to obtain vaccine batch issuance qualifications, and optimizing the medical insurance negotiation mechanism can help Chengdu-Chongqing create an integrated ecosystem of "R&D-approval-application" for biopharmaceuticals, inject strong momentum into narrowing the industrial gap between the east and the west, and jointly building a western health industry base, and promote the implementation of national strategies.

https://finance.eastmoney.com/a/202503043335163320.html